InsiderTrades.com logo

VRXA Insider Trading

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $82,650.00
Insider Selling (Last 12 Months): $0.00

Veraxa Biotech Insider Trading History Chart

This chart shows the insider buying and selling history at Veraxa Biotech by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Veraxa Biotech Share Price & Price History

Current Price: $1.35
Price Change: ▲ Price Increase of +1.35 (∞)
As of 08/31/2026 04:00 PM ET

This chart shows the closing price history over time for VRXA up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Veraxa Biotech Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/27/2026Christoph Rudiger AntzCEOBuy5,000$1.53$7,650.005,000View SEC Filing Icon  
8/27/2026Oliver Rolf BaumannDirectorBuy50,000$1.50$75,000.005,773,618View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Veraxa Biotech (NASDAQ:VRXA)

Veraxa Biotech logo
VERAXA Biotech AG develops antibody-based therapeutics and antibody-drug conjugates for cancer treatment. The company develops antibody-based therapeutics, including antibody-drug conjugates and bispecific antibody formats, and offers a proprietary technology platform for functional antibody screening and bioconjugation. Its product pipeline includes drug candidates such as ADCs and BITACs, with some in clinical development, and it provides partnership models for collaborative development from target identification to antibody and ADC creation. The company utilizes proprietary payloads and genetic code expansion technology to engineer and manufacture homogeneous, stable bioconjugates with defined drug-to-antibody ratios. It also licenses technology platforms to support the development of new therapeutic strategies. The company serves professional clients in the healthcare sector, including those in drug development, biologicals, diagnostics, instrumentation, and partners with research organizations and business partners in the life sciences industry. The company was founded in 2021 and is based in Heidelberg, Germany.
Read More on Veraxa Biotech

Today's Range

Now: $1.35
Low: $1.32
High: $1.39

50 Day Range

MA: N/A

52 Week Range

Now: $1.35
Low: $1.32
High: $27.36

Volume

294,506 shs

Average Volume

552,236 shs

Market Capitalization

$42.69 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.26

Who are the company insiders with the largest holdings of Veraxa Biotech?

Veraxa Biotech's top insider shareholders include:
  1. Oliver Rolf Baumann (Director)
  2. Christoph Rudiger Antz (CEO)
Learn More about top insider investors at Veraxa Biotech.